Articles tagged with Multiple Sclerosis
Researchers found that dimethyl fumarate treatment increased the proportion of beneficial gut bacteria and reduced pro-inflammatory types, which are associated with MS. The study suggests a potential connection between gut flora and clinical side effects, paving the way for personalized treatment approaches.
A recent study published in Nature Computational Science reveals that specific regions of the brain process both individual and combined words, while others focus solely on individual words. The research could contribute to the development of wearable neurotechnology devices that can decode language directly from brain activity.
A University of Arizona Health Sciences study found that people over 45 with Type 2 diabetes treated with anti-hyperglycemic medications had a higher risk of multiple sclerosis, especially among women. In contrast, anti-hyperglycemic exposure in those under 45 reduced the risk.
Researchers used native top-down mass spectroscopy to study the interplay between glycans and oligomerization in various therapeutic hormones and cytokines. They found that glycans significantly stabilize some proteins, such as tumor necrosis factor-α, while others, like interferon-β, are independent of glycosylation status.
Researchers developed guidelines to communicate brain atrophy to MS patients, minimizing misunderstanding and apprehension. The new model ensures patients receive vital information about their disease progression, improving quality of life.
Researchers identified Spns2, an S1P transporter, as a novel drug target for Multiple Sclerosis treatment. Targeting this protein may improve safety profiles and reduce side effects associated with current therapies.
Researchers from the University of Zurich have discovered why a stem cell transplant is effective in treating multiple sclerosis. The study found that memory T cells reappear immediately after the transplant and do not trigger an autoimmune reaction due to pre-damage caused by chemotherapy. This knowledge enables the body to gradually ...
Research published in Journal of Neurology Neurosurgery & Psychiatry found that obesity at MS diagnosis is associated with higher current and subsequent levels of disability. Reverting to a healthy weight may improve clinical outcomes for obese patients with MS, suggesting a modifiable risk factor.
Researchers at UCLA have identified an animal model that shares similarities with progressive multiple sclerosis, enabling studies of disability-improving treatments. The model reveals neurodegeneration features and effects on various parts of the brain and spinal cord, holding promise for future treatment discovery.
A VUB study has mapped the immune system's response to brain infections, revealing that resident macrophages play a key role in defending against pathogens. The researchers found that blood-derived immune cells can eliminate parasites, but may retain 'memory' of past infections, altering their ability to respond to future insults.
A team of researchers used digital cameras and machine learning algorithms to develop a system that can predict gait dysfunctions in people with multiple sclerosis and Parkinson's disease. The study revealed that several algorithms were over 75% accurate at detecting differences between those with the conditions and those without.
Robotic exoskeletons have been shown to provide intensive high-quality rehabilitation and potentially improve functional outcomes in individuals with MS. However, experts agree that wide acceptance depends on further clinical studies aimed at determining optimal selection criteria and long-term outcomes.
A machine learning model developed by Carnegie Mellon University can accurately predict how stay-at-home orders affect people with multiple sclerosis. The model uses passively gathered smartphone and fitness tracker data to identify factors that signal changes in health.
A Kessler Foundation study found a relationship between rate of cognitive fatigue in MS and microstructural brain changes, particularly in white matter tracts and basal ganglia. The study's findings hold promise for advancing clinical interventions for disabling fatigue.
A new study led by Erika Pearce at Johns Hopkins Medicine found that the shape and function of mitochondria in Th17 cells play a crucial role in controlling their autoimmune activity. The researchers identified several molecules, including LKB1, that can influence this process, paving the way for potential therapeutic modifications.
A diet rich in guar gum fibre has been shown to limit inflammation and delay the onset of multiple sclerosis (MS) symptoms in mice. The study found that only guar gum significantly reduced MS-like symptoms, suggesting its potential as a therapeutic approach for humans.
Researchers replaced zebrafish GPR17 receptor gene with human version to study myelin repair in multiple sclerosis. Testing substances in modified fish larvae may lead to quicker and more successful human trials.
Research findings suggest that aerobic fitness, cognitive processing speed, and walking endurance are strongly associated in individuals with thalamic atrophy. Aerobic exercise training may be beneficial in restoring function for those with this biomarker of neurodegeneration.
A large-scale international study has identified dozens of gut bacteria associated with multiple sclerosis, revealing potential new mechanisms for disease development and treatment response. The study also found geographical location and participant's disease status as significant factors influencing gut microbiome variations.
The National Multiple Sclerosis Society awards Kessler Foundation a five-year grant to continue the long-running MS Fellowship in Neuropsychological Rehabilitation program. The grant provides funding for postdoctoral fellows to work on rehabilitation research projects.
A new analysis shows that health care spending may explain the link between multiple sclerosis (MS) and latitude, with higher MS rates found in wealthier countries. The study, published in Neurology, adjusted data for other factors to find a strong association between health expenditure per capita and MS prevalence.
A MedUni Vienna study has identified retinal layer thinning as a reliable prognostic marker for multiple sclerosis severity. The analysis revealed that thinner retinas are associated with increased risk of permanent disability and more aggressive treatment is recommended.
A new study found that people with multiple sclerosis may experience varying levels of physical and mental quality of life depending on factors such as age at diagnosis, income, and disability level. Researchers identified specific subgroups with distinct profiles, highlighting the need for early interventions to improve outcomes.
A new study reveals that a multiple sclerosis treatment, interferon beta, reduces the binding of key molecules to red blood cells, thereby decreasing inflammation and slowing disease progression. This breakthrough discovery has significant implications for the treatment of this debilitating autoimmune disease.
Researchers at Heinrich-Heine University Duesseldorf discovered that corticosteroid Medrysone promotes oligodendroglial cell replacement and myelin sheath restoration. Astrocytes play a surprising role in mediating this effect, with some promoting tissue repair and others contributing to lesion formation.
The National MS Society has launched 40 new research awards to explore myelin repair, clues to MS progression, and wellness strategies to move closer to a world free of MS. The $19 million investment is part of a projected total of nearly $30 million in 2022 to support over 250 new research studies.
A team of experts encourages further investigation into the benefits of exercise training for managing multiple sclerosis. They argue that available studies are poorly designed and lack measurable neurological damage, suggesting that rigorous trials could provide evidence for neuroprotection.
A phase 3 clinical trial found that patients with relapsing-remitting multiple sclerosis treated with rituximab had a five-fold lower risk of relapse compared to those receiving standard dimethyl fumarate treatment. Rituximab also showed fewer new MS plaques on magnetic resonance imaging.
A study from the University of Kansas found that social support was crucial in predicting good sleep quality among individuals with multiple sclerosis. The research, conducted during the pandemic, revealed that tangible and positive social interaction support significantly predicted better sleep quality.
Researchers from Kessler Foundation found that virtual reality (VR) technology can strengthen the effects of traditional cognitive rehabilitation and exercise training in individuals with MS. By increasing sensory input and promoting multisensory integration, VR may increase the effectiveness of these therapies.
A comprehensive online survey of people with multiple sclerosis found that improving social integration and reducing social isolation can promote and maintain health and wellbeing. The study suggests that these social factors significantly predict health and wellbeing, even when accounting for demographic factors.
Researchers found that tenascin C and tenascin R impede the regeneration of myelin sheaths in mice with multiple sclerosis. Mice lacking these proteins rebuilt their myelin sheaths faster and more effectively.
Researchers at Karolinska Institutet have successfully repurposed a cancer drug to target neuroinflammatory diseases like multiple sclerosis. A novel drug carrier was developed to deliver the treatment specifically to microglia, reducing inflammation and disease progression.
Researchers at Cedars-Sinai have comprehensively mapped molecular activity in the brain and spinal cord that regulates body's response to central nervous system (CNS) disorders. They discovered a critical role of astrocytes, specialized support cells, in regulating outcomes for CNS disorders.
Kessler Foundation researchers use signal detection theory to characterize cognitive fatigue in multiple sclerosis. The study reveals an association between subjective 'state' fatigue, response bias, and brain activation patterns in both MS and control groups. This finding supports the use of signal detection metrics as an objective me...
Researchers develop targeted delivery system to boost regulatory T cells, which manage inflammation and reduce brain damage. The treatment increases IL2 levels, allowing regulatory T cells to survive and reducing cognitive impairment.
Researchers have developed a new tool to visualize leukocytes in the brain vasculature during in vivo two-photon laser scanning microscopy. The tool uses a fluorescent antibody targeting CD45, a ubiquitously expressed protein on white blood cells, allowing for tracking of circulating leukocytes over time and space.
A recent study found that aquatic exercise is preferred by individuals with multiple sclerosis and can provide significant benefits for those with the condition. However, lack of access to pools and high costs are major barriers to participation.
Researchers found that MS patients treated with Rituximab who have higher B cell counts of 40/µL or more develop protective levels of antibodies after vaccination. This suggests that measuring B cell level before vaccination is crucial for increasing the chance of a positive response.
Researchers found glatiramer acetate to be compatible with breastfeeding, reducing the frequency of relapses in multiple sclerosis patients. The study's results indicate no negative effects on infant development, leading to updates in the drug's label and approval for treatment during the breastfeeding period.
Researchers at Kessler Foundation found significant improvement in processing speed among individuals with MS after a five-week training intervention. The treatment effect was maintained six months later, with dosage correlating with improved outcomes.
Researchers have demonstrated the efficacy of a six-week interpersonal emotion regulation (IER) intervention for addressing depression often experienced by individuals with multiple sclerosis. IER strategies, such as turning to others for emotional support, significantly reduced depression levels in the treatment group.
A new study published in Neurology found that women with multiple sclerosis (MS) are less likely to have breast cancer detected through routine screenings, despite being twice as likely to have colorectal cancer detected at an early stage. The researchers also found a higher rate of disability among MS patients, which may affect their ...
Researchers at Karolinska Institutet have developed a method to identify the immune cells involved in autoimmune diseases and identified four new target molecules for personalized treatment of multiple sclerosis. This approach could lead to more precise treatments with fewer side effects, potentially benefiting other autoimmune diseases.
A new study finds that multiple sclerosis (MS) affects Black and white adults at similar rates, while being underreported in Hispanic and Asian communities. The study analyzed over 2.6 million adults in Southern California and found MS prevalence per 100,000 people was similarly high for Black and white people, but lower among Hispanic...
Researchers at Universitat Autonoma de Barcelona developed a new treatment that reduces chronic inflammation in multiple sclerosis mice models by administering Maresin-1, a lipid mediator. The substance significantly reduced cytokine levels and protected neurons from demyelination.
A new report estimates the total economic burden of multiple sclerosis (MS) in the United States to be over $85 billion, with direct medical costs reaching $63.3 billion and indirect non-medical costs totaling $22.1 billion. The average excess medical cost per person with MS was found to be $65,612.
Researchers developed EMOPRINT, a five-week behavioral intervention improving facial affect recognition skills in individuals with MS. The study showed significant improvement in facial affect recognition in the MS group compared to placebo controls.
Researchers analyzed genomic profiles of over one million cells from 1,000 people, identifying a link between specific genes and immune cell types in autoimmune diseases. The discovery could lead to tailored treatments and refine clinical trials.
Research published in the Journal of Neurology Neurosurgery & Psychiatry found a strong association between childhood emotional trauma and an increased risk of multiple sclerosis (MS) in women. Women who experienced childhood abuse, particularly sexual abuse, were more likely to develop MS compared to those without a history of abuse.
A new study by University of Alberta immunologist Shokrollah Elahi reveals that killer T cells have low levels of protein CD73, compromising their ability to eliminate HIV-infected cells. Chronic inflammation also plays a role in reducing CD73 expression, leading to potential new treatments for both HIV and multiple sclerosis.
Researchers at Mayo Clinic have developed a new antibody test to diagnose multiple sclerosis (MS), a potentially disabling disease of the brain and spinal cord. The validated test measures kappa immunoglobulin free light chains in cerebrospinal fluid, offering a faster and more cost-effective alternative to existing tests.
A new study published in Multiple Sclerosis and Related Disorders found that individuals with multiple sclerosis experienced increased depression, anxiety, and loneliness during the COVID-19 pandemic. The research suggests that pandemic-related stress may exacerbate mental health issues in MS patients.
A new study led by Kelly Monaghan at West Virginia University suggests that interrupting the immune response may improve multiple sclerosis outcomes. The researchers found that targeting a specific protein called CCL17 can prevent the disease from attacking the central nervous system, leading to milder symptoms and delayed paralysis.
Researchers identified key differences in metabolic processes between brain and spinal cord oligodendrocytes, which could lead to new therapeutic treatments for neurodegenerative diseases. The study also found that targeting a specific cell protein may enhance cholesterol and myelin production.
A new study found that a ketogenic diet significantly improves MS symptoms, including fatigue, depression, and cognitive function. Patients on the keto diet experienced reductions in neurologic disability and enhanced overall quality of life.
A study published in Nature Communications reveals the precise molecular structure of siponimod, a multiple sclerosis drug, and its interactions with S1P receptors. This knowledge may lead to the development of more targeted therapies that reduce side effects.
A new study by University of Bonn researchers found that cow's milk protein casein triggers an autoimmune response in mice, damaging neurons and myelin sheath. This cross-reactivity can occur when the immune system mistakes similar molecules for each other.
New research found that people with multiple sclerosis used online telehealth services more frequently to stay in contact with healthcare providers and were highly satisfied with the outcome. Telehealth appointments nearly doubled the rates of in-person medical care appointments.
Scientists create a hybrid technology called heteroduplex oligonucleotide (HDO) that can safely and effectively silence disease-causing genes in certain immune cells. The HDO delivery method has shown promise in improving symptoms of autoimmune disorders and cancers by regulating the function of T and B lymphocytes.